• About Us
  • Contact Us
Saturday, July 2, 2022
Sada El balad
Supervisor
Elham AbolFateh
Editor in Chief
Mohamed Wadie
  • Home
  • News
  • Business
  • Schools & Universities
  • Arts & Culture
  • Entertainment
  • Hospitality
    • Food & Beverage
    • Travel & Tourism
    • Lodging
    • Recreation
  • Sports
  • MORE
    • Lifestyle
    • Opinion & Analysis
    • Technology
    • In-depth
    • Videos & Features
  • صدي البلد جامعات
  • صدي البلد عقارات
No Result
View All Result
  • Home
  • News
  • Business
  • Schools & Universities
  • Arts & Culture
  • Entertainment
  • Hospitality
    • Food & Beverage
    • Travel & Tourism
    • Lodging
    • Recreation
  • Sports
  • MORE
    • Lifestyle
    • Opinion & Analysis
    • Technology
    • In-depth
    • Videos & Features
  • صدي البلد جامعات
  • صدي البلد عقارات
No Result
View All Result
Sada El balad
Supervisor
Elham AbolFateh
Editor in Chief
Mohamed Wadie

Pfizer Starts Clinical Trials for Coronavirus Children Pills

Rana Atef by Rana Atef
8:53 PM March 10, 2022
China Approves Use of Pfizer's COVID Pill Paxlovid
Share on FacebookShare on Twitter

Pfizer announced that it started the final stages of its new COVID-19 pills for non-hospitalized children aged between six to 17 years old and are at a high risk of severe illness, Al Ain reported on Thursday.

Known as Paxlovid, the drug has been authorized for emergency use in the US for kids who are older than 12 years old and at high risk of severe symptoms.

140 children were enlisted in the study of the drugmaker, and they were divided into two groups according to weight differences.

Pfizer’s Chief of Scientific Officer Mikael Dolsten said: “Since the beginning of the pandemic, more than 11 million children under the age of 18 in the United States alone have tested positive for COVID-19, representing nearly 18% of reported cases and leading to more than 100,000 hospital admissions.”

Advertisements

Leading pharmaceutical and biotechnology firms Pfizer and BioNTech announced the beginning of the clinical trials for their vaccine that targets the Omicron COVID-19 variant, the Brussels Times reported on Tuesday.

The earliest stage of the clinical trials will include 1420 people and they will be divided into three groups.

Three main features of the vaccine would be evaluated and they are tolerability, efficacy, and safety.

The CEO of BioNTech Ugur Sahin said in a press release: “The study is part of our scientific approach to develop a variant-based vaccine that provides similar protection against Omicron as we observed with the previous variants, which also lasts longer.”

Regarding the division of the groups, the first group would contain 605 participants and they received two doses of the available vaccine between 90 and 180 days before the study and they will now receive one or two doses of the newly developed one for Omicron.

Tags: CoronavirusCOVID-19Pfizer

Related Posts

 Palestinian FM Calls for  International Investigation into  Death  of Prisoner Saadiya Farajallah
LATEST STORIES

 Palestinian FM Calls for  International Investigation into  Death  of Prisoner Saadiya Farajallah

July 2, 2022
Serbia: 1 Killed, 6 Injured in Exchange of Fire Between Migrants
News

Serbia: 1 Killed, 6 Injured in Exchange of Fire Between Migrants

July 2, 2022
Donald Trump
LATEST STORIES

CNN: Trump Seriously Considers Announcing Candidacy for US Presidency This Month

July 2, 2022
China's Foreign Minister Wang Yi © Reuters
News

China’s FM Visits Myanmar amid Protest

July 2, 2022
Ukraine Denies Escalating Military Activity on Belarus Border
News

Ukraine Denies Escalating Military Activity on Belarus Border

July 2, 2022
India: Rescuers Recover 26 Bodies from Mudslide
News

India: Rescuers Recover 26 Bodies from Mudslides

July 2, 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Stories

Egypt's Planning Minister Reveals Country's Performance In Indicators of SDGs
Economy

Planning Min.: Egypt Allocates 40% of Investments in the 22/2023 plan in Green Projects

by Ahmed Moamar
June 27, 2022
0

Dr. Hala Al-Saeed, Minister of Planning and Economic Development, said that the reform efforts and the diversity of sectors that...

SCZONE Hosts Roundtable Discussions with Green Fuel Companies ICW EBRD

SCZONE Hosts Roundtable Discussions with Green Fuel Companies ICW EBRD

June 29, 2022
Traditional Fashion Is Trendy at All Times

Traditional Fashion Is Trendy at All Times

June 27, 2022
6 Ways to Stay Fit on Summer Vacation

6 Ways to Stay Fit on Summer Vacation

July 1, 2022
Amr Diab

Amr Diab Drops Song “El Look El Geded”

June 30, 2022

We Chose for You

Egypt's Planning Minister Reveals Country's Performance In Indicators of SDGs
Economy

Planning Min.: Egypt Allocates 40% of Investments in the 22/2023 plan in Green Projects

by Ahmed Moamar
June 27, 2022
0

Dr. Hala Al-Saeed, Minister of Planning and Economic Development, said that the reform efforts and the diversity of sectors that...

SCZONE Hosts Roundtable Discussions with Green Fuel Companies ICW EBRD

SCZONE Hosts Roundtable Discussions with Green Fuel Companies ICW EBRD

June 29, 2022
Traditional Fashion Is Trendy at All Times

Traditional Fashion Is Trendy at All Times

June 27, 2022
6 Ways to Stay Fit on Summer Vacation

6 Ways to Stay Fit on Summer Vacation

July 1, 2022
Amr Diab

Amr Diab Drops Song “El Look El Geded”

June 30, 2022
  • News
  • Antiques
  • Travel & Tourism
  • Business
  • Youth & Education
  • Sports
  • Arts & Culture
  • Lifestyle
  • Technology
  • Entertainment
  • Videos & Features
  • Opinion & Analysis

© 2019 see news -powered by 3a digital.

No Result
View All Result
  • Home
  • News
  • Business
  • Schools & Universities
  • Arts & Culture
  • Entertainment
  • Hospitality
    • Food & Beverage
    • Travel & Tourism
    • Lodging
    • Recreation
  • Sports
  • MORE
    • Lifestyle
    • Opinion & Analysis
    • Technology
    • In-depth
    • Videos & Features
  • صدي البلد جامعات
  • صدي البلد عقارات

© 2019 see news -powered by 3a digital.